Turkish Journal of Medical Sciences
Volume 51, Number SI-1 (2021)
Cover and Contents
Articles
Achievements of the COVID-19 Turkey Platform in vaccine and drug development withan approach of "co-creation and succeeding together"
HASAN MANDAL
Pages 3139-3149
Turkey's response to COVID-19 pandemic: strategy and key actions
GÜLŞEN BARLAS, HARUN ÖZTÜRK, GÜLEN PEHLİVANTÜRK, and SABAHATTİN AYDIN
Pages 3150-3156
One and a half years into the COVID-19 pandemic - exit strategies and efficacy of SARSCoV-2 vaccines for holistic management and achieving global control
ESKILD PETERSEN, AYŞE DENİZ GÖKENGİN, ASMA AL BALUSHI, and ALIMUDDIN ZUMLA
Pages 3157-3161
Going back to normal, but how? Re-opening policies and the standards for a new normal
LEVENT AKIN
Pages 3162-3167
Managing life during the pandemic: communication strategies, mental health, and theultimate toll of the COVID-19
MEHMET HAKAN TÜRKÇAPAR, YASEMİN KAHYA, TUĞBA ÇAPAR TAŞKESEN, and HATİCE IŞIK
Pages 3168-3181
Short-term impact of the Covid-19 pandemic on the global and Turkish economy
ÖMER AÇIKGÖZ and ASLI GÜNAY
Pages 3182-3193
Global health emergencies during the pandemic and their solutions
İRFAN ŞENCAN, DİLEK BULUT, İSMAİL HAKKI ŞENCAN, and CANAN AĞALAR
Pages 3194-3206
Nonpharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic
MUSTAFA NECMİ İLHAN, HAKAN TÜZÜN, RAHMİ KILIÇ, and NURAN YILDIRIM
Pages 3207-3214
Current infection prevention and control strategies of COVID-19 in hospitals
GAMZE KALIN ÜNÜVAR, MEHMET DOĞANAY, and EMİNE ALP
Pages 3215-3220
Pandemic hospitals and reorganizing emergency departments
AFŞİN EMRE KAYIPMAZ and AHMET DEMİRCAN
Pages 3221-3228
Evaluating the efficiency of public policy measures against COVID-19
HATİCE RAHMET GÜNER, İMRAN HASANOĞLU, and FİRDEVS AKTAŞ
Pages 3229-3237
How efficient are facial masks against COVID-19? Evaluating the mask use of variouscommunities one year into the pandemic
Aslıhan CANDEVİR, CEM ÜNGÖR, FİGEN ÇİZMECİ ŞENEL, and YEŞİM TAŞOVA
Pages 3238-3245
RNA-Based COVID-19 vaccine candidates with clinical phase trials in progress
LEYLA İPEK RUDVAN AL, MELİHA ÇAĞLA SÖNMEZER, and SERHAT ÜNAL
Pages 3246-3252
Epidemiology of COVID-19: What changed in one year?
CEMAL BULUT and YASUYUKİ KATO
Pages 3253-3261
From asymptomatic to critical illness - different clinical manifestations of COVID-19 inchildren
HASAN TEZER and MELİS DENİZ
Pages 3262-3272
Multisystem inflammatory syndrome in children
SELDA HANÇERLİ TÖRÜN, DİLEK YILMAZ ÇİFTDOĞAN, and ATEŞ KARA
Pages 3273-3283
From asymptomatic to critical illness: decoding various clinical stages of COVID-19
İLHAMİ ÇELİK and RECEP ÖZTÜRK
Pages 3284-3300
COVID-19 and Sepsis
ZELİHA KOÇAK TUFAN, BİRCAN KAYAASLAN, and MERVYN MER
Pages 3301-3311
Pregnancy and COVID-19: prevention, vaccination, therapy, and beyond
DİLEK ŞAHİN, ATAKAN TANAÇAN, SOPHIA NE WEBSTER, and ÖZLEM MORALOĞLU TEKİN
Pages 3312-3326
The radiological findings of COVID-19
ALPER KARACAN, YAKUP ERSEL AKSOY, and MEHMET HALİL ÖZTÜRK
Pages 3327-3339
The timing of intubation and principles of ICU care in COVID-19
SEMA TURAN, SULTAN SEVİM YAKIN, and HÜSEYİN LEVENT YAMANEL
Pages 3340-3349
Implementation of post-intensive care outpatient clinic (I-POINT) for critically illCOVID-19 survivors
BURÇİN HALAÇLI and ARZU TOPELİ İSKİT
Pages 3350-3358
Post-COVID syndrome: pulmonary complications
DORİNA ESENDAĞLI, AYDIN YILMAZ, MÜŞERREF ŞULE AKÇAY, and TEVFİK ÖZLÜ
Pages 3359-3371
An update of anti-viral treatment of COVID-19
SERAP YAVUZ and FERİDE İPEK KOMSUOĞLU ÇELİKYURT
Pages 3372-3390
Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for thetreatment of hyperinflammation
ABDURRAHMAN TUFAN and MARCO MATUCCI-CERINIC
Pages 3391-3404
Editors
- Editor-in-Chief
- Prof. Dr. Murat KEKİLLİ Gazi University
- Associate Editors-in-Chief
- Prof. Dr. Selim ARICI Ondokuz Mayis University
- Prof. Dr. Kürşat ALTINBAŞ Selçuk University
- Prof. Dr. Zehra Sema ÖZKAN Kırıkkale University
